Cardinal Capital Management LLC (Connecticut)’s Trinity Biotech TRIB Stock Holding History

Cardinal Capital Management LLC (Connecticut)’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,661	Closed	-$9.71M	–	96
2015 Q3	$9.71M	Sell	5,661 -308	-5%	-$743K	0.61%	55
2015 Q2	$16.2M	Sell	5,969 -142	-2%	-$369K	0.86%	41
2015 Q1	$17.6M	Sell	6,111 -49	-0.8%	-$136K	0.97%	35
2014 Q4	$16.2M	Sell	6,160 -197	-3%	-$509K	0.94%	38
2014 Q3	$17.4M	Buy	6,357 +613	+11%	+$1.99M	1.08%	36
2014 Q2	$19.8M	Buy	5,744 +1,536	+37%	+$5.46M	1.07%	34
2014 Q1	$15.3M	Buy	4,208 +478	+13%	+$1.88M	0.8%	44
2013 Q4	$14.1M	Buy	3,730 +2,166	+138%	+$7.8M	0.75%	46
2013 Q3	$5.11M	Buy	1,564 +1,455	+1,335%	+$4.26M	0.31%	66
2013 Q2	$275K	Buy	+109	New	+$271K	0.02%	83

Other funds holding TRIB

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Cardinal Capital Management LLC (Connecticut)'s TRIB Position: Q4 2015 in Review

Cardinal Capital Management LLC (Connecticut) sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 5,661 shares — an estimated $9.71M sold.

Cardinal Capital Management LLC (Connecticut) first reported a position in TRIB in Q2 2013 and held it in 10 quarters. The position peaked at $19.8M in Q2 2014. 81 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

Cardinal Capital Management LLC (Connecticut) reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
Cardinal Capital Management LLC (Connecticut) sold 5,661 Trinity Biotech shares in Q4 2015, an estimated $9.71M.
Cardinal Capital Management LLC (Connecticut) first reported a position in Trinity Biotech in Q2 2013 and held it in 10 quarters.
Cardinal Capital Management LLC (Connecticut)'s Trinity Biotech position peaked at $19.8M in Q2 2014.
81 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on Cardinal Capital Management LLC (Connecticut)'s 13F filing for Q4 2015, filed 16 Feb 2016.